title: [Study on ultrastructure of cardioprotection of ramipril against ischemia/reperfusion injury in diabetic rats].
abstract: OBJECTIVE
  To investigate the effects of ramipril on myocardial ischemia/reperfusion injury in diabetic rats, and to explore its mechanism according to the observation on myocardial ultrastructure.
  
  
  METHODS
  Streptozotocin induced diabetic rats were divided randomly into three groups (n = 16): ischemia/reperfusion (I/R), ischemic preconditioning (IPC) and ramipril (RAM) group. Rats in RAM group were administered by RAM(1 mg x kg(-1) x d(-1)) orally for 4 weeks, the others were administered by normal saline. Then all rats were subjected to myocardial ischemia/ reperfusion injury. Rats in IPC group were preconditioned before ischemia. The ECG and the infarct size were examined. The changes of myocardial morphology were examined by light and electron microscopes.
  
  
  RESULTS
  Compared with I/R group, the elevation of ST segment and the incidence of ventricular tachycardia and ventricular fibrillation during ischemia were significantly decreased, the infarct size at the end of reperfusion was remarkably reduced, the myocardial morphology were significantly improved, special structure of myofilaments and mitochondria remained clearly, blood vessels were unobstructed, injury of endothelium were decreased in PC and RAM groups.
  
  
  CONCLUSIONS
  Ramipril administered for 4 weeks induces myocardial protection in diabetic rats, which is similar to that of IPC. The mechanism may be involved in protection of cardiocytes and mitochondria, and improvement of endothelial function.
authors.affiliation: Department of Pharmacology, Tianjin Medical University, Tianjin 300070, China.
authors.forename: Yan-Na
authors.initials: YN
authors.lastname: Wu
authors.forename: Yan
authors.initials: Y
authors.lastname: Chen
authors.forename: Zhe
authors.initials: Z
authors.lastname: Zhang
authors.forename: Ya-Li
authors.initials: YL
authors.lastname: Dong
authors.forename: Xue-Kuan
authors.initials: XK
authors.lastname: Yu
authors.forename: Jian-Jie
authors.initials: JJ
authors.lastname: Jiao
authors.forename: Yi
authors.initials: Y
authors.lastname: Kang
authors.forename: Wei-Zhen
authors.initials: WZ
authors.lastname: Gao
authors.forename: Jian-Shi
authors.initials: JS
authors.lastname: Lou
authors.forename: Yan-Xia
authors.initials: YX
authors.lastname: Liu
mesh_terms: D000818:Animals; D002316:Cardiotonic Agents / Q000494:pharmacology; D003921:Diabetes Mellitus, Experimental / Q000150:complications*; D019157:Ischemic Preconditioning, Myocardial / Q000379:methods*; D015428:Myocardial Reperfusion Injury / Q000473:pathology / Q000517:prevention & control*; D009206:Myocardium / Q000648:ultrastructure*; D017257:Ramipril / Q000494:pharmacology*; D051381:Rats
chemical_list: D002316:Cardiotonic Agents; D017257:Ramipril